Vascular Sensitivity to Adrenergic Agonists in Patients With CHF and in Healthy Subjects
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00782782
Verified October 2008 by Hadassah Medical Organization. Recruitment status was: Active, not recruiting
Congestive Heart failure (CHF) is asociated with changes in cardiac function and vascular responses. The aim of this study is to characterize these differences. Our hypothesis is, that there are differences in vascular responses between healthy subjects and patients with CHF.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years to 70 Years (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Patients with congestive heart failure NYHA I-II and healthy subjects
Patients with congestive heart failure NYHA I-II
Stable clinical condition
Resting systolic blood pressure < 100
Resting heart rate < 50
Hypersensitivity to dexmedetomidine, phenylephrine, isoproterenol, terbutaline